These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 19441088

  • 1. Screening options for Down syndrome: how women choose in real clinical setting.
    Lo TK, Lai FK, Leung WC, Lau WL, Ng LS, Wong WC, Tam SS, Yee YC, Choi H, Lam HS, Sham AS, Tang LC, Chin RK.
    Prenat Diagn; 2009 Sep; 29(9):852-6. PubMed ID: 19441088
    [Abstract] [Full Text] [Related]

  • 2. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
    Spencer K, Aitken D.
    Ultrasound Obstet Gynecol; 2004 Dec; 24(7):735-9. PubMed ID: 15505874
    [Abstract] [Full Text] [Related]

  • 3. Sequential and contingent prenatal screening for Down syndrome.
    Wald NJ, Rudnicka AR, Bestwick JP.
    Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
    [Abstract] [Full Text] [Related]

  • 4. Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate?
    Mulvey S, Zachariah R, McIlwaine K, Wallace EM.
    Prenat Diagn; 2003 Oct; 23(10):828-32. PubMed ID: 14558028
    [Abstract] [Full Text] [Related]

  • 5. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.
    Chan LW, Chau MC, Leung TY, Fung TY, Leung TN, Lau TK.
    Prenat Diagn; 2005 Dec; 25(13):1248-52. PubMed ID: 16353273
    [Abstract] [Full Text] [Related]

  • 6. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM, Ghidini A, Alvis C, Hodor J, Landy HJ, Poggi SH.
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [Abstract] [Full Text] [Related]

  • 7. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R, Duchange N, Vayssière C, Kohler M, Bouffard N, Hunsinger MC, Kohler A, Mager C, Neumann M, Vayssière C, Viville B, Hervé C, Moutel G.
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [Abstract] [Full Text] [Related]

  • 8. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening.
    Seror V, Ville Y.
    Prenat Diagn; 2009 Feb; 29(2):120-8. PubMed ID: 19123253
    [Abstract] [Full Text] [Related]

  • 9. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [Abstract] [Full Text] [Related]

  • 10. Options for Down syndrome screening: what will women choose?
    Grant SS.
    J Midwifery Womens Health; 2005 Jul; 50(3):211-8. PubMed ID: 15894999
    [Abstract] [Full Text] [Related]

  • 11. Patient preferences for screening in the first trimester.
    Werner EF, Pastore LM, Karns LB, Ventura KA, Saller DN.
    Prenat Diagn; 2008 Dec; 28(13):1251-5. PubMed ID: 19097030
    [Abstract] [Full Text] [Related]

  • 12. Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice.
    Weisz B, Pandya P, Chitty L, Jones P, Huttly W, Rodeck C.
    BJOG; 2007 Apr; 114(4):493-7. PubMed ID: 17309546
    [Abstract] [Full Text] [Related]

  • 13. A new policy for prenatal screening and diagnosis of Down syndrome for pregnant women with advanced maternal age in a public hospital.
    Lo TK, Lai FK, Leung WC, Lau WL, Tang LC, Chin RK.
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):914-9. PubMed ID: 19883260
    [Abstract] [Full Text] [Related]

  • 14. Pregnant women's knowledge and attitudes to prenatal screening for fetal chromosomal abnormalities: Croatian multicentric survey.
    Kosec V, Zec I, Tislarić-Medenjak D, Kuna K, Simundić AM, Lajtman-Krizaić M, Lovrić B, Mimica M, Estatiev ZK, Borgudan V.
    Coll Antropol; 2013 Jun; 37(2):483-9. PubMed ID: 23940994
    [Abstract] [Full Text] [Related]

  • 15. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ, Kuo YS, Hsu JJ, Shyu MK, Hsieh TT, Hsieh FJ.
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [Abstract] [Full Text] [Related]

  • 16. First-trimester Down syndrome screening: pregnant women's knowledge.
    Dahl K, Hvidman L, Jørgensen FS, Henriques C, Olesen F, Kjaergaard H, Kesmodel US.
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
    [Abstract] [Full Text] [Related]

  • 17. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K, Sandall J.
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
    Jaques AM, Sheffield LJ, Halliday JL.
    Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.